Acro Biomedical Balance Sheet Health
Financial Health criteria checks 3/6
Acro Biomedical has a total shareholder equity of $339.7K and total debt of $79.0K, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are $539.1K and $199.5K respectively.
Key information
23.3%
Debt to equity ratio
US$78.97k
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.68k |
| Equity | US$339.65k |
| Total liabilities | US$199.49k |
| Total assets | US$539.15k |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACBM's short term assets ($526.2K) exceed its short term liabilities ($199.5K).
Long Term Liabilities: ACBM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ACBM's net debt to equity ratio (22.5%) is considered satisfactory.
Reducing Debt: ACBM's debt to equity ratio has increased from 18.1% to 23.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ACBM has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ACBM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.